Regenerating CNS myelin - from mechanisms to experimental medicines. (Q49986398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Regenerating CNS myelin - from mechanisms to experimental medicines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Charles Ffrench-Constant

series ordinal

object named as

Charles Ffrench-Constant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

1 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Neuroscience

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

753-769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29142295%20AND%20SRC:MED&resulttype=core&format=json

Why does remyelination fail in multiple sclerosis?

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination in the CNS: from biology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination is extensive in a subset of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination can be extensive in multiple sclerosis despite a long disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neuroprotection and repair in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Central remyelination restores secure conduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendroglia metabolically support axons and contribute to neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendroglia: metabolic supporters of axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

The node of Ranvier in CNS pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

The Nodes of Ranvier: Molecular Assembly and Maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination protects axons from demyelination-associated axon degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Extensive remyelination of the CNS leads to functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Constitutively active Akt induces enhanced myelination in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Impaired adult myelination in the prefrontal cortex of socially isolated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Motor skill learning requires active central myelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Dynamics of oligodendrocyte generation and myelination in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Platelet-derived growth factor promotes repair of chronically demyelinated white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Pattern of remyelination in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Activation of oligodendroglial Stat3 is required for efficient remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

The polarity protein Scribble regulates myelination and remyelination in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Ascl1/Mash1 promotes brain oligodendrogenesis during myelination and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

NG2-glia as multipotent neural stem cells: fact or fantasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Synantocytes: new functions for novel NG2 expressing glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Proliferating bipotential glial progenitor cells in adult rat optic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocyte precursor cells modulate the neuronal network by activity-dependent ectodomain cleavage of glial NG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocyte progenitors: adult stem cells of the central nervous system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Subependymal Zone-Derived Oligodendroblasts Respond to Focal Demyelination but Fail to Generate Myelin in Young and Aged Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

ERK1/2 Activation in Preexisting Oligodendrocytes of Adult Mice Drives New Myelin Synthesis and Enhanced CNS Function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neurotoxic reactive astrocytes are induced by activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Astrocyte-derived endothelin-1 inhibits remyelination through notch activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Notch receptor activation inhibits oligodendrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Apcdd1 stimulates oligodendrocyte differentiation after white matter injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Daam2-PIP5K is a regulatory pathway for Wnt signaling and therapeutic target for remyelination in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

c-Myc-dependent transcriptional regulation of cell cycle and nucleosomal histones during oligodendrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRN.2017.136

21 January 2018

https://api.crossref.org/works/10.1038%2FNRN.2017.136

The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Targeting human oligodendrocyte progenitors for myelin repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

lncRNA Functional Networks in Oligodendrocytes Reveal Stage-Specific Myelination Control by an lncOL1/Suz12 Complex in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Axonal neuregulin-1 regulates myelin sheath thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Stimulation of monocytes, macrophages, and microglia by amphotericin B and macrophage colony-stimulating factor promotes remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Differentiation and death of premyelinating oligodendrocytes in developing rodent brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Inefficient clearance of myelin debris by microglia impairs remyelinating processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Regenerative Capacity of Macrophages for Remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Differential roles of microglia and monocytes in the inflamed central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Origin, fate and dynamics of macrophages at central nervous system interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Efficient central nervous system remyelination requires T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Stimulation of adult oligodendrogenesis by myelin-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Stem cells and healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Age at disability milestones in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination capacity of the MS brain decreases with disease chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Rejuvenation of regeneration in the aging central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Rejuvenating Strategies for Stem Cell-Based Therapies in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Retinoid X receptor gamma signaling accelerates CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Pathophysiology of the brain extracellular matrix: a new target for remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

LINGO-1 negatively regulates myelination by oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Liver X receptors regulate cholesterol homeostasis in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Olesoxime accelerates myelination and promotes repair in models of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Dietary cholesterol promotes repair of demyelinated lesions in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

A regenerative approach to the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

CNS myelin wrapping is driven by actin disassembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Transplantation of CNS fragments into the brain of shiverer mutant mice: extensive myelination by implanted oligodendrocytes. I. Immunohistochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Transplantation of glial cells into the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Neural stem cell engraftment and myelination in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Imaging outcomes for trials of remyelination in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Advanced MRI and staging of multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

In vivo quantitative magnetization transfer imaging correlates with histology during de- and remyelination in cuprizone-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Dynamic imaging of individual remyelination profiles in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Multiple sclerosis: remyelination of nascent lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Myelination and the trophic support of long axons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Myelinated nerve fibers: computed effect of myelin thickness on conduction velocity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Efficient Remyelination Requires DNA Methylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Understanding multiple sclerosis: lessons from pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Distinct origins, gene expression and function of microglia and monocyte-derived macrophages in CNS myelin injury and regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Remyelination occurs as extensively but more slowly in old rats compared to young rats following fliotoxin-induced CNS demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Decline in rate of colonization of oligodendrocyte progenitor cell (OPC)-depleted tissue by adult OPCs with age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Tocopherol derivative TFA-12 promotes myelin repair in experimental models of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRN.2017.136

Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis

31 March 2020

1 reference

12 December 2020

Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis

1 reference

12 December 2020

Quantifying the early stages of remyelination following cuprizone-induced demyelination.

1 reference

12 December 2020

Understanding CNS remyelination: clues from developmental and regeneration biology

1 reference

12 December 2020

Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency

1 reference

12 December 2020

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

1 reference

12 December 2020